Coppersmith Presentation to Alere Inc Stockholders

PAGE 14 | COPPERSMITH ▪ Alere stockholder value has deteriorated and vastly underperformed both the stock market generally and healthcare companies specifically (as defined by the Company's own chosen comparables from their Form 10-K) > Alere's total return -59% as of 6/28/13 > -66% worse than the NYSE Composite > -113% worse the Dow Jones US Healthcare Index Stock Performance Since Inception of the HM Strategy¹ $180 $160 $140 $120 $100 $80 $60 $40 $20 Whentary $0 Oct-07 Feb-08 Jun-08 Oct-08 Feb-09 Jun-09 Oct-09 Feb-10 Jun-10 Oct-10 Feb-11 Jun-11 Oct-11 Feb-12 Jun-12 Oct-12 Feb-13 Jun-13 -ALR -NYSE Composite -DJ US HC Index

View entire presentation